Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Citation: Boominathan, L., MiRNA-based anti-metastasis therapy: MiRNA-139 decreases the expression of PD-1, a suppressor of activation of T-cells, and activates the immune system via down regulation of its target gene, 29/April/2015, 7.33 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
It has recently been shown that blocking PD-1 with antibodies one could make tumors shrink. This work, relating to Cancer immunotherapy, has been chosen as Science’s breakthrough of the year.
The study presented here suggests that MiRNA-139, by decreasing the expression of its target gene, it may suppress the expression of PD-1. Thereby, it may activate the immune system and inhibit metastatic progression. Thus, pharmacological formulations encompassing “MiRNA-139 activators“ may be used to inhibit the progression of tumors.
Undisclosed information: How MiRNA-139 suppresses the expression of PD-1
Courtesy: When you cite drop us a line at firstname.lastname@example.org